HOHamideh Taheri Olyayie

Hamideh Taheri Olyayie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hamideh Taheri Olyayie has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • From tumor reduction to behavioral improvement and cytokine balance: Therapeutic role of petroleum ether extract of Teucrium polium in a rat model of C6-induced glioblastoma

    by Hamideh Taheri Olyayie, Seyed Noureddin Nematollahi-Mahani, Saeideh Jafarinejad-Farsangi, Fatemeh Sheikhbahaei, Mitra Mehrabani, Fahimeh Pourjafari, Azadeh Shahrokhi, Ali Shamsara, Hamideh Bashiri

    This study aimed to investigate the therapeutic effects of the petroleum ether extract of Teucrium polium (T. polium) on cognitive behaviors, oxidative stress, interleukin-1 beta (IL-1β) and interleukin10 (IL-10) cytokines, tumor volume, and survival rate on C6-induced glioblastoma multiforme (GBM) in rats. The rats were randomly divided into seven groups (n = 10): sham, tumor, vehicle, Temozolomide (TMZ), and T. polium at doses of 1, 2, 4 mg/kg. Behavioral assessments were performed using the open field test (OFT), elevated plus maze (EPM), rotarod test (RT), and passive avoidance test (PAT) to examine anxiety-like behavior, motor function, and memory. Positron Emission Tomography (PET( imaging was performed on day 25. Histopathological changes, and Ki-67 were assessed using Hematoxylin and Eosin (H&E) and Immunohistochemistry (IHC), and the tumor area was measured. Malondialdehyde (MDA), total antioxidant capacity (TAC), and IL-1β and IL-10 cytokines in brain tissue were evaluated. Survival rate was also assessed for three months. T. polium, especially at a dose of 2 mg/kg could inhibit GBM proliferation and reduce tumor area and Fluorodeoxyglucose )FDG( uptake. T. polium, particularly at the higher doses, improved anxiety-like behaviour and motor dysfunction. IL-1β and IL-10 reduced in the treatment groups. It should be mentioned that T. polium could not improve memory, survival rate, and oxidant status. Considering the anti-anxiety and anti-tumor properties of T. polium and its neuroprotective effects in rats with GBM, it may be regarded as a complementary therapeutic agent to TMZ in the treatment of GBM. Further studies are needed to clarify the underlying mechanisms and their clinical significance.